Hosted on MSN3mon
Basic research leads to drug candidates for fatal lung diseaseMolecules activating only the AT2 receptor In particular, they were interested in being able to steer and activate the angiotensin II type 2 receptor (AT2 receptor), which is one of two receptors ...
GLP-1 receptor agonists were initially approved for glycaemic control in type 2 diabetes and, subsequently, for bodyweight loss in obesity. Following large-scale trials demonstrating that some GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results